Treatment of epidermal growth factor receptor inhibitor-induced skin toxicities: do the data support the current practice?

被引：0
|
作者：
Cotliar, Jonathan [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA
来源：
SUPPORTIVE CARE IN CANCER | 2011年 / 19卷 / 10期
关键词：
TRIAL; CANCER; IMPACT;
D O I：
10.1007/s00520-011-1234-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1481 / 1482
页数：2
相关论文
共 50 条
  • [21] Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor-induced pruritus
    Gerber, Peter Arne
    Buhren, Bettina Alexandra
    Cevikbas, Ferda
    Boelke, Edwin
    Steinhoff, Martin
    Homey, Bernhard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (01) : 163 - 165
  • [22] Management of epidermal growth factor receptor (EGFR) inhibitor-related skin toxicities across Europe
    Lemmens, L.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2010, 14 : S60 - S61
  • [23] Efficacy of topical epidermal growth factor cream for patients with epidermal growth factor receptor inhibitor-induced acneiform eruption: a randomized controlled trial
    Lee, J. H.
    Ju, H. J.
    Kwon, H. S.
    Jung, H. M.
    Kim, G. M.
    Bae, J. M.
    An, H. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (01) : 219 - 221
  • [24] Psychosocial Impact of Cutaneous Toxicities Associated With Epidermal Growth Factor Receptor-Inhibitor Treatment
    White, Kathryn J.
    Roydhouse, Jessica K.
    Scott, Kathleen
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2011, 15 (01) : 88 - 96
  • [25] Effectiveness of Epidermal Growth Factor containing Moisture Cream for treatment of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI)-induced cutaneous toxicities.
    Lee, Sung Yong
    Moon, Jae Young
    Lee, Sang Yeub
    Kim, Je Hyeong
    Shin, Chol
    Shim, Jae Jeong
    In, Kwang Ho
    Yoo, Se Hwa
    Kang, Kyung Ho
    Kim, Jun Suk
    Song, Hae Jun
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S895 - S895
  • [26] Distinct cytokine profiles of epidermal growth factor receptor (EGFR) inhibitor-induced papulopustular eruption (PPE)
    Takata, Tomoya
    Tarutani, Masahito
    Sano, Shigetoshi
    JOURNAL OF DERMATOLOGY, 2010, 37 : 32 - 32
  • [27] Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab
    Suh, KY
    Kindler, HL
    Medenica, M
    Lacouture, M
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (01) : 191 - 192
  • [28] Initial Characterization of Menadione Topical Lotion for the Prevention and Treatment of Skin Toxicities Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
    Imperiale, S. Michael
    Hagey, Anne E.
    Silverman, Jeffrey A.
    Deitcher, Steven R.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S961 - S962
  • [29] Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer
    Melosky, Barbara
    Anderson, Helen
    Burkes, Ronald L.
    Chu, Quincy
    Hao, Desiree
    Ho, Vincent
    Ho, Cheryl
    Lam, Wendy
    Lee, Christopher W.
    Leighl, Natasha B.
    Murray, Nevin
    Sun, Sophie
    Winston, Robert
    Laskin, Janessa J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (08) : 810 - +
  • [30] Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients
    Lee, Ji Su
    Woo, Jimin
    Kim, Tae Min
    Kim, Namkyu
    Keam, Bhumsuk
    Jo, Seong Jin
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
12345